Fennec Pharmaceuticals Inc. Common Stock

€8.574
EUR
Last updated on --.
24h volume218.12K
24h highest8.7161 EUR
24h lowest8.3413 EUR
24h Price movement+0.81%

FENC recent prices

24 Hours
+0.81%+€0.0688
30 days
+49.87%+€2.873
60 days
+74.02%+€3.673
90 days
+18.27%+€1.333

Key data

Previous close8.5054 EUR
Market cap291.27M EUR
Volume218.12K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.20640 EUR
Net income (FY)-7.20M EUR
Revenue (FY)43.86M EUR
Last report dateMay 14, 2026

About Fennec Pharmaceuticals Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
HeadquartersRESEARCH TRIANGLE PARK
Employees (FY)35.00
Revenue per employee (FY)1.25M EUR
Net income per employee (FY)-205.81K EUR
Listed onNasdaq
Official website

FENC conversion tables

FENCFENC
EUREUR
0.5 FENC4.287 EUR
1 FENC8.574 EUR
5 FENC42.87 EUR
10 FENC85.74 EUR
EUREUR
FENCFENC
0.5 EUR0.058314 FENC
1 EUR0.11663 FENC
5 EUR0.58314 FENC
10 EUR1.166 FENC

FAQ

FENC is trading at €8.574, +0.81% over the last 24 hours. Track live moves on the price chart at the top of this page.
The FENC stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. FENC is currently trading at €8.574, +0.81% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on FENC price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. FENC's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from FENC; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against FENC's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Fennec Pharmaceuticals Inc. Common Stock's market cap is currently 291.27M EUR. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume218.12K
24h highest8.7161 EUR
24h lowest8.3413 EUR
24h Price movement+0.81%
FENCFENC
EUREUR
Start trade with FENC Perpetual